Get the Stockscreener App
0.00
100.00%
-7.90
After Hours:
7.68
7.68
+
Addex Therapeutics Ltd Adr stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
See More
Previous Close:
$7.90
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$8.64M
Revenue:
$630.00K
Net Income/Loss:
$5.72M
P/E Ratio:
0.00
EPS:
-0.3415
Net Cash Flow:
$-6.75M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$7.90
52-Week Range:
$0.00
$13.27
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Name
Addex Therapeutics Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare ADXN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
0.00 | 8.64M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Upgrade | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Stock (ADXN) Latest News
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress - Investing.com
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
LYRA Stock Quote Price and Forecast - CNN
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr Stock (ADXN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):